FIELD: biotechnology.
SUBSTANCE: invention includes a plasmid obtained on the basis of the px601 vector and encoding the SaCas9 protein and guide RNA against the sequence fragment of exon 3 of the Bos taurus CD209 gene, intended for the assembly of adeno-associated viruses, as well as a method for obtaining Bos taurus embryos and their subsequent transduction with the obtained adeno-associated viruses to obtain mosaic knockouts for the CD209 gene.
EFFECT: development of a method of obtaining a knockout of the CD209 gene in Bos taurus embryos by transducing zygotes with adeno-associated viruses encoding SaCas9 and the corresponding guide RNA.
2 cl, 2 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ENHANCING TARGETED EDITING OF THE CXCR4 GENE IN HUMAN CD4 LYMPHOCYTES IN ORDER TO CREATE CELL RESISTANCE TO HIV-1 | 2021 |
|
RU2779300C1 |
GENOMIC DNA EDITING SYSTEM OF AN EUKARYOTIC CELL BASED ON THE NUCLEOTIDE SEQUENCE ENCODING THE SUCAS9NLS PROTEIN | 2022 |
|
RU2804422C1 |
METHOD FOR EDITING THE GJB2 GENE TO CORRECT THE PATHOGENIC VARIANT OF c.del35G IN HUMAN CELLS CULTURED IN VITRO | 2021 |
|
RU2780677C1 |
METHOD OF PRODUCING MOUSE MODEL FOR STUDYING DUCHENNE MUSCULAR DYSTROPHY AND VERSIONS OF ITS THERAPY | 2023 |
|
RU2815936C1 |
DNA-CUTTING AGENT BASED ON Cas9 PROTEIN FROM THE BACTERIUM STREPTOCOCCUS UBERIS NCTC3858 | 2022 |
|
RU2788197C1 |
DNA POLYMER BASED ON Cas9 PROTEIN FROM BIOTECHNOLOGICALLY SIGNIFICANT BACTERIUM CLOSTRIDIUM CELLULOLYTICUM | 2018 |
|
RU2712497C1 |
METHOD FOR PRODUCING GENETICALLY MODIFIED LABORATORY ANIMALS WITH NULL ALLELE OF P2rx3 GENE | 2022 |
|
RU2805173C1 |
DNA-CUTTING AGENT BASED ON THE Cas9 PROTEIN FROM THE BACTERIUM CAPNOCYTOPHAGA OCHRACEA | 2021 |
|
RU2778156C1 |
DNA CUTTER BASED ON THE ScCas12a PROTEIN FROM THE BACTERIUM SEDIMENTISPHAERA CYANOBACTERIORUM | 2022 |
|
RU2791447C1 |
METHOD OF PRODUCING GENETICALLY MODIFIED MICE EXPRESSING HUMAN ANTITHROMBIN III MINIGENE USING MICROINJECTIONS OF TELN-LINEARIZED DNA FRAGMENT | 2022 |
|
RU2806568C1 |
Authors
Dates
2023-08-01—Published
2022-11-30—Filed